Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.1B bought by 543 insiders at 338 companies
- $8.9B sold by 642 insiders outside a trading plan
- $4.6B sold by 953 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$158M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$138M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
-
GSATGlobalstar, Inc.James Monroe IIIDirector$29.8M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
NVDANvidia Corporation ComMark A StevensDirector$300M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
-
LFSTLifeStance Health Group, Inc.Tpg Gp A, LLC10% owner · +2 joint filers$226M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yuh-Jier Mii COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
John Wendell Thompson DirectorRBRKRubrik, Inc.Planned sale$1.6M 13,500 shares at $115.69Traded Oct 1 Filed Oct 2
-
Scott Bender CEOWHDCactus, Inc.Planned sale$6.2M 100,000 shares at $61.97 45% of stakeTraded Oct 1 Filed Oct 2
-
Markus Gloeckler Chief Technology OfficerFSLRFirst Solar, Inc.Planned sale$139K 800 shares at $174.00 14% of stakeTraded Oct 1 Filed Oct 2
-
Hollings Renton DirectorANABAnaptysBio, Inc.Planned sale$249K 5,000 shares at $49.87 31% of stakeTraded Oct 1 Filed Oct 2
-
Eric Venker CEOROIVRoivant Sciences Ltd.Planned sale$7.3M 200,000 shares at $36.62 11% of stakeTraded Sep 30 Filed Oct 2
-
Daniel J Bartlett Executive Vice PresidentWMTWalmart Inc.Planned sale$417K 3,990 shares at $104.41 0.6% of stakeTraded Oct 1 Filed Oct 2
-
Christine Ring Chief Legal OfficerNRIXNurix Therapeutics, Inc.Planned sale$134K 5,786 shares at $23.19 39% of stakeTraded Oct 2 Filed Oct 2
-
Glenn Steele Jr. MD PHD DirectorPTCTPTC Therapeutics, Inc.Planned sale$782K 12,000 shares at $65.16 35% of stakeTraded Sep 30 Filed Oct 2
-
Adam C. Spice CFORKLBRocket Lab CorporationPlanned sale$9.9M 140,157 shares at $70.82 11% of stakeTraded Oct 1 Filed Oct 2
-
Raymond Woo Chief Technology OfficerCBLLCeriBell, Inc.Planned sale$119K 4,887 shares at $24.38 2.3% of stakeTraded Oct 1 Filed Oct 2
-
Joshua Hexter COOORMPOramed Pharmaceuticals Inc.Planned sale$135K 30,000 shares at $4.51 2.2% of stakeTraded Oct 1 Filed Oct 2
-
Dan Paterson CEOVSTMVerastem, Inc.Planned sale$353K 44,121 shares at $8.00 6.3% of stakeTraded Oct 1 Filed Oct 2
-
Aaron Jagdfeld CEOGNRCGenerac Holdings Inc.Planned sale$1M 5,000 shares at $206.00 0.9% of stakeTraded Oct 1 Filed Oct 2
-
Jeffrey Jacob Raider DirectorWRBYWarby Parker Inc.Planned sale$416K 15,000 shares at $27.70 3.4% of stakeTraded Oct 1 Filed Oct 2
-
Neil Harris Blumenthal CEOWRBYWarby Parker Inc.Planned sale$2.8M 100,000 shares at $27.69 74% of stakeTraded Oct 1 Filed Oct 2
-
Aman Joshi Chief Commercial OfficerBEBloom Energy CorporationPlanned sale$2.3M 8,437 shares at $277.17 5.4% of stakeTraded Oct 1 Filed Oct 2
-
Yat Tung Lam COOCRDOCredo Technology Group Holding LtdPlanned sale$10.3M 50,000 shares at $205.22 2.2% of stakeTraded Oct 1 Filed Oct 2
-
Michelle F. Link Chief of Human ResourcesMMSMaximus, Inc.Planned sale$174K 3,208 shares at $54.23 19% of stakeTraded Oct 1 Filed Oct 2
-
Thomas C Indelicarto EVP, Gen Counsel & SecretaryVRSNVerisign Inc.Planned sale$142K 500 shares at $284.38 1.5% of stakeTraded Oct 1 Filed Oct 2
-
Kevin McCulloch See RemarksXERSXeris Biopharma Holdings, Inc.Planned sale$141K 15,000 shares at $9.41 0.9% of stakeTraded Oct 1 Filed Oct 2
-
Beth Hecht See RemarksXERSXeris Biopharma Holdings, Inc.Planned sale$157K 16,666 shares at $9.41 1.5% of stakeTraded Oct 1 Filed Oct 2
-
Timothy Pierce Morningstar EVP, Chief Growth OfficerBJBJ's Wholesale Club Holdings, Inc.Sale$457K 4,856 shares at $94.09 13% of stakeTraded Oct 1 Filed Oct 2
-
William C. Werner EVP, Strategy & DevelopmentBJBJ's Wholesale Club Holdings, Inc.Sale$285K 3,000 shares at $95.00 5.6% of stakeTraded Oct 1 Filed Oct 2
-
Mark J. Darling Chief Retail OfficerHRBH&R Block, Inc.Sale$110K 2,700 shares at $40.69 11% of stakeTraded Sep 30 Filed Oct 2
-
Eric Stokes SVP and Group President of WTSNWPXNWPX Infrastructure, Inc.Planned sale$1.3M 12,353 shares at $103.38 33% of stakeTraded Oct 1 Filed Oct 2
-
Sudhir Gopalswamy Group President, AMG & ISGONON Semiconductor CorporationPlanned sale$1.2M 15,578 shares at $80.00 9% of stakeTraded Oct 1 Filed Oct 2
-
Daniel Patrick O'Day CEOGILDGilead Sciences Inc.Planned sale$2.2M 15,000 shares at $147.90 2.6% of stakeTraded Oct 1 Filed Oct 2
-
Matthew L. Posard DirectorHALOHalozyme Therapeutics, Inc.Planned sale$568K 5,230 shares at $108.54 8.9% of stakeTraded Oct 1 Filed Oct 2
-
Cole G. Carter Chief Administrative OfficerCXWCoreCivic, Inc.Planned sale$400K 12,500 shares at $32.02 7% of stakeTraded Oct 1 Filed Oct 2
-
Peter Toth EVP, Chief Sustain & Dev OffNEMNewmont CorporationPlanned sale$344K 3,000 shares at $114.81 8% of stakeTraded Oct 1 Filed Oct 2
-
Salvatore A Miosi COOMTGMGIC Investment CorporationPlanned sale$782K 30,000 shares at $26.06 6.4% of stakeTraded Oct 1 Filed Oct 2
-
Timothy J. Mattke CEOMTGMGIC Investment CorporationPlanned sale$3.6M 137,114 shares at $26.24 14% of stakeTraded Oct 1 Filed Oct 2
-
Natascha Viljoen CEONEMNewmont CorporationPlanned sale$446K 3,882 shares at $114.81 3% of stakeTraded Oct 1 Filed Oct 2
-
Daniel Freifeld DirectorMRTMarti Technologies, Inc.Sale$2.6M 1,350,000 shares at $1.91 18% of stakeTraded May 18–Sep 9 Filed Oct 2
-
Soleil Boughton Chief Legal OfficerHIMSHims & Hers Health, Inc.Planned sale$101K 3,461 shares at $29.17 1.1% of stakeTraded Sep 30 Filed Oct 2
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$5.5M 9,500 shares at $576.47 2.8% of stakeTraded Oct 1 Filed Oct 2
-
Tim Foote CFOBBBlackBerry LimitedSale$152K 16,672 shares at $9.14 23% of stakeTraded Oct 1 Filed Oct 2
-
Philip S. Kurtz CLO & Corp. SecretaryBBBlackBerry LimitedSale$274K 30,000 shares at $9.14 32% of stakeTraded Sep 30 Filed Oct 2
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$3.3M 34,000 shares at $97.09 16% of stakeTraded Oct 1–2 Filed Oct 2
-
Paul Cahill Sciarra DirectorJOBYJoby Aviation, Inc.Planned sale$381K 62,500 shares at $6.09 0.1% of stakeTraded Oct 2 Filed Oct 2
-
John Sheldon Serafini CEOHAWKHawkEye 360, Inc.Planned sale$1.4M 92,329 shares at $14.78 14% of stakeTraded Oct 1 Filed Oct 2
-
Wajid Ali CFOLITELumentum Holdings Inc.Planned sale$25.7M 24,542 shares at $1,048.50 25% of stakeTraded Oct 1 Filed Oct 2
-
Ulrike Helfer DirectorGSLGlobal Ship Lease, Inc.Sale$179K 4,000 shares at $44.82 32% of stakeTraded Sep 30 Filed Oct 2
-
Edward Meyercord CEOEXTRExtreme Networks, Inc.Planned sale$1.1M 50,000 shares at $21.77 2.8% of stakeTraded Oct 1 Filed Oct 2
-
Jason V Coloma CEOMAZEMaze Therapeutics, Inc.Planned sale$932K 34,501 shares at $27.02 15% of stakeTraded Oct 1 Filed Oct 2
-
Jennifer Tejada ChairPDPagerDuty, Inc.Planned sale$1.6M 107,000 shares at $15.11 6.4% of stakeTraded Sep 30 Filed Oct 2
-
Asif Ali CFOPTGXProtagonist Therapeutics, Inc.Planned sale$8.3M 58,629 shares at $141.78 50% of stakeTraded Sep 30 Filed Oct 2
-
Harold Bernstein President, R&D & CMOMAZEMaze Therapeutics, Inc.Planned sale$435K 16,141 shares at $26.93 100% of stakeTraded Oct 1 Filed Oct 2
-
William D Mosley CEOSTXSeagate Technology Hldngs PlPlanned sale$10.3M 11,002 shares at $935.60 2.9% of stakeTraded Oct 1 Filed Oct 2
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,792 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.